Category: LUNG CANCER MARKER   |   Code: A3102

EGFR Mutation Express(4 Exons)

EGFR Mutation Express(4 Exons)
Icon Function


The EGFR mutation test is useful for determining the suitability of tyrosine kinase inhibitor (TKI) therapy in patients with non-small cell lung cancer (NSCLC). EGFR mutations are present in 38-43% of lung adenocarcinomas, and determine response to drugs such as erlotinib, afatinib, and gefitinib. This assay includes mutations at exon points 18-21, including the T790M mutation that can predict resistance to TKI therapy.

Test Schedule Estimated Test Result Container Substance Stability
Monday - Friday 2 days - FFPE Block, Rinse Room temperature
Icon Terms


The block must contain tumor cells

Icon Methods


High Resolution Melting (HRM) PCR dan Restriction Fragment Length Polymorphism (RFLP)

Icon Reference

Score Reference